Effects of Recombinant Human Angiotensin-Converting Enzyme 2 on Response to Acute Hypoxia and Exercise: A Randomised, Placebo-Controlled Study-Reference-Cited by-同舟云学术

Effects of Recombinant Human Angiotensin-Converting Enzyme 2 on Response to Acute Hypoxia and Exercise: A Randomised, Placebo-Controlled Study

Published:2021-06-26 Issue:2 Volume:7 Page:487-501
ISSN:2364-1754
Container-title:Pulmonary Therapy
language:en
Short-container-title:Pulm Ther

Author:

Hall David A.^ORCID,Hanrott Kate,Badorrek Philipp,Berliner Dominik,Budd David C.,Eames Rhena,Powley William M.,Hewens Deborah,Siederer Sarah,Lazaar Aili L.,Cahn Anthony,Hohlfeld Jens M.

Funder

glaxosmithkline

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine,Respiratory Care

Link

https://link.springer.com/content/pdf/10.1007/s41030-021-00164-7.pdf

Reference22 articles.

1. Cargill RI, Lipworth BJ. Lisinopril attenuates acute hypoxic pulmonary vasoconstriction in humans. Chest. 1996;109:424–9.

2. Nong Z, Stassen JM, Moons L, Collen D, Janssens S. Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling. Circulation. 1996;94:1941–7.

3. de Man FS, Tu L, Handoko ML, et al. Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186:780–9.

4. Camelo JS Jr, Hehre D, Devia C, Camelo SH, Bancalari E, Suguihara C. The role of angiotensin II receptor-1 blockade in the hypoxic pulmonary vasoconstriction response in newborn piglets. Neonatology. 2008;93:263–8.

5. Bader M. ACE2, angiotensin-(1–7), and Mas: the other side of the coin. Pflugers Arch. 2013;465:79–85.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of the pharmacokinetics of soluble ACE2 decoy receptors through glycosylation;Molecular Therapy - Methods & Clinical Development;2024-09

2. Human hypoxia models in aerospace medicine: Potential applications for human pharmacological research;British Journal of Clinical Pharmacology;2024-03-31

3. Autoregulation: mediators and renin–angiotensin system in diseases and treatments;Future Journal of Pharmaceutical Sciences;2023-04-07

4. Renin–angiotensin–aldosterone system inhibitors. New and old approaches;Angiotensin;2023

5. A hitchhiker's guide through the COVID-19 galaxy;Clinical Immunology;2021-11